Portfolio company
Correlia Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Correlia Biosystems develops automated microfluidic immunoassay platforms for protein quantification, serving biopharmaceutical, cell and gene therapy, and synthetic biology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
Charlot Biosciences
This company develops microfluidic hardware for non-destructive live cell analysis and bioprocess monitoring to support biopharmaceutical researchers and cell therapy manufacturers.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Partillion Bio
This company produces nanovial reagent kits for single-cell analysis and sorting, serving pharmaceutical, biotechnology and academic research laboratories.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
